The management of anticoagulation in patients undergoing therapeutic plasma exchange: A concise review

On behalf of the Therapeutic Apheresis Subsection of the AABB

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

We surveyed multiple apheresis centers represented by the authors for their clinical approach to the management of anticoagulation issues during therapeutic plasma exchange (TPE). We present the results of their practices and a review of the pertinent literature. As plasma is removed during TPE, replacement with all or partial non-plasma-containing fluids (eg, 5% albumin) may lead to significant changes in hemostasis. These changes are amplified in patients who are receiving anticoagulation. We discuss various anticoagulants as well as the monitoring and adjustment of anticoagulation before, during, and after TPE. No single guideline can be applied, but rather, patients must be monitored individually, taking into account their often complex clinical conditions and medication profiles.

Original languageEnglish (US)
Pages (from-to)371-379
Number of pages9
JournalJournal of Clinical Apheresis
Volume33
Issue number3
DOIs
StatePublished - Jun 2018

Fingerprint

Plasma Exchange
Blood Component Removal
Hemostasis
Anticoagulants
Albumins
Therapeutics
Guidelines

Keywords

  • direct oral anticoagulants
  • direct thrombin inhibitors
  • low molecular weight heparins
  • platelet inhibitors
  • unfractionated heparin

ASJC Scopus subject areas

  • Hematology

Cite this

The management of anticoagulation in patients undergoing therapeutic plasma exchange : A concise review. / On behalf of the Therapeutic Apheresis Subsection of the AABB.

In: Journal of Clinical Apheresis, Vol. 33, No. 3, 06.2018, p. 371-379.

Research output: Contribution to journalReview article

On behalf of the Therapeutic Apheresis Subsection of the AABB. / The management of anticoagulation in patients undergoing therapeutic plasma exchange : A concise review. In: Journal of Clinical Apheresis. 2018 ; Vol. 33, No. 3. pp. 371-379.
@article{8971ec775f3b47749b2d940b4f997816,
title = "The management of anticoagulation in patients undergoing therapeutic plasma exchange: A concise review",
abstract = "We surveyed multiple apheresis centers represented by the authors for their clinical approach to the management of anticoagulation issues during therapeutic plasma exchange (TPE). We present the results of their practices and a review of the pertinent literature. As plasma is removed during TPE, replacement with all or partial non-plasma-containing fluids (eg, 5{\%} albumin) may lead to significant changes in hemostasis. These changes are amplified in patients who are receiving anticoagulation. We discuss various anticoagulants as well as the monitoring and adjustment of anticoagulation before, during, and after TPE. No single guideline can be applied, but rather, patients must be monitored individually, taking into account their often complex clinical conditions and medication profiles.",
keywords = "direct oral anticoagulants, direct thrombin inhibitors, low molecular weight heparins, platelet inhibitors, unfractionated heparin",
author = "{On behalf of the Therapeutic Apheresis Subsection of the AABB} and Shunkwiler, {Sara M.} and Pham, {Huy P.} and Geoffrey Wool and Ipe, {Tina S.} and Fang, {Deanna C.} and Elizabeth Biller and Angela Treml and John Weiss and Baron, {Beverly W.} and Mary Berg",
year = "2018",
month = "6",
doi = "10.1002/jca.21592",
language = "English (US)",
volume = "33",
pages = "371--379",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - The management of anticoagulation in patients undergoing therapeutic plasma exchange

T2 - A concise review

AU - On behalf of the Therapeutic Apheresis Subsection of the AABB

AU - Shunkwiler, Sara M.

AU - Pham, Huy P.

AU - Wool, Geoffrey

AU - Ipe, Tina S.

AU - Fang, Deanna C.

AU - Biller, Elizabeth

AU - Treml, Angela

AU - Weiss, John

AU - Baron, Beverly W.

AU - Berg, Mary

PY - 2018/6

Y1 - 2018/6

N2 - We surveyed multiple apheresis centers represented by the authors for their clinical approach to the management of anticoagulation issues during therapeutic plasma exchange (TPE). We present the results of their practices and a review of the pertinent literature. As plasma is removed during TPE, replacement with all or partial non-plasma-containing fluids (eg, 5% albumin) may lead to significant changes in hemostasis. These changes are amplified in patients who are receiving anticoagulation. We discuss various anticoagulants as well as the monitoring and adjustment of anticoagulation before, during, and after TPE. No single guideline can be applied, but rather, patients must be monitored individually, taking into account their often complex clinical conditions and medication profiles.

AB - We surveyed multiple apheresis centers represented by the authors for their clinical approach to the management of anticoagulation issues during therapeutic plasma exchange (TPE). We present the results of their practices and a review of the pertinent literature. As plasma is removed during TPE, replacement with all or partial non-plasma-containing fluids (eg, 5% albumin) may lead to significant changes in hemostasis. These changes are amplified in patients who are receiving anticoagulation. We discuss various anticoagulants as well as the monitoring and adjustment of anticoagulation before, during, and after TPE. No single guideline can be applied, but rather, patients must be monitored individually, taking into account their often complex clinical conditions and medication profiles.

KW - direct oral anticoagulants

KW - direct thrombin inhibitors

KW - low molecular weight heparins

KW - platelet inhibitors

KW - unfractionated heparin

UR - http://www.scopus.com/inward/record.url?scp=85032284961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032284961&partnerID=8YFLogxK

U2 - 10.1002/jca.21592

DO - 10.1002/jca.21592

M3 - Review article

C2 - 29071747

AN - SCOPUS:85032284961

VL - 33

SP - 371

EP - 379

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 3

ER -